0001437749-22-019620.txt : 20220809
0001437749-22-019620.hdr.sgml : 20220809
20220809162319
ACCESSION NUMBER: 0001437749-22-019620
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220805
FILED AS OF DATE: 20220809
DATE AS OF CHANGE: 20220809
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Points Jeffrey S.
CENTRAL INDEX KEY: 0001731414
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-52082
FILM NUMBER: 221148687
MAIL ADDRESS:
STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC.
STREET 2: 1225 OLD HIGHWAY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiovascular Systems Inc
CENTRAL INDEX KEY: 0001180145
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 411698056
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 651-259-1600
MAIL ADDRESS:
STREET 1: 1225 OLD HWY 8 NW
CITY: ST. PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: REPLIDYNE INC
DATE OF NAME CHANGE: 20020813
4
1
rdgdoc.xml
FORM 4
X0306
4
2022-08-05
0001180145
Cardiovascular Systems Inc
CSII
0001731414
Points Jeffrey S.
1225 OLD HIGHWAY 8 NW
ST. PAUL
MN
55112
1
Chief Financial Officer
Common Stock
2022-08-05
4
A
0
18916
0
A
128228
D
Common Stock
2022-08-05
4
A
0
56747
0
A
184975
D
Restrictions lapse as to 6,306 shares on 8/13/23 and as to 6,605 shares on each of 8/13/24 and 8/13/25.
Subject to performance-based forfeiture of 28,374 shares based on the Company's three-year total shareholder return for fiscal years 2023, 2024 and 2025 versus the Company's peer group, and for 28,373 shares based on the Company's average annual revenue growth in fiscal years 2023, 2024 and 2025.
/s/ Andrew Nick as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed.
2022-08-09